A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Data
- Pdf file
Supplementary Table 1
- docx file
Supplementary Table 2
- docx file